E
Edward J. Holland
Researcher at University of Minnesota
Publications - 191
Citations - 7374
Edward J. Holland is an academic researcher from University of Minnesota. The author has contributed to research in topics: Transplantation & Corneal transplantation. The author has an hindex of 47, co-authored 182 publications receiving 6513 citations. Previous affiliations of Edward J. Holland include University of Cincinnati.
Papers
More filters
Journal ArticleDOI
The evolution of epithelial transplantation for severe ocular surface disease and a proposed classification system.
Journal ArticleDOI
A new system, the LipiFlow, for the treatment of meibomian gland dysfunction.
Stephen S. Lane,Harvey Dubiner,Randy J. Epstein,Paul H. Ernest,Jack V. Greiner,David R. Hardten,Edward J. Holland,Michael A. Lemp,James E. McDonald,David I. Silbert,Caroline A. Blackie,Christy A. Stevens,Raman Bedi +12 more
TL;DR: The LipiFlow System was significantly more effective than the iHeat Warm Compress for adults with meibomian gland dysfunction and dry eye symptoms and these results support its safety and effectiveness in the treatment of MGD and Dry eye symptoms.
Journal ArticleDOI
Classification of herpes simplex virus keratitis.
TL;DR: By categorizing cases of HSV keratitis by their primary anatomic and pathophysiologic etiologic characteristics, clinicians can better understand and therefore treat all types of HSv ker atitis.
Journal ArticleDOI
Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results.
Jonathan H. Lass,Robin L. Gal,Mariya Dontchev,Roy W. Beck,Craig Kollman,Steven P. Dunn,Ellen Heck,Edward J. Holland,Mark J. Mannis,Monty M. Montoya,Robert L. Schultze,Stulting Rd,Alan Sugar,Joel Sugar,Bradley Tennant,David D. Verdier +15 more
TL;DR: There is a slight association between cell loss and donor age in the 5 years after corneal transplantation and the importance of longer-term follow-up of this cohort to determine if this relationship affects graft survival.
Journal ArticleDOI
Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
Joseph Frucht-Pery,Joel Sugar,Jules L. Baum,John E. Sutphin,Jacob Pe'er,Hana Savir,Edward J. Holland,David M. Meisler,Jill A. Foster,Robert Folberg,Yaacob Rozenman +10 more
TL;DR: In this paper, the authors evaluated the efficacy and risks of topical mitomycin C (MMC) for conjunctival-corneal intraepithelial neoplasia (CCIN).